
Lignonir 2% Injection
Marketer
Aculife Healthcare Private Limited
Salt Composition
Lidocaine (2%)
Overview Lignonir 2% Injection
Lignonir 2% Injection provides localized anesthesia for minor surgical procedures, including dental, oral, diagnostic, and other therapeutic interventions. Administered solely by healthcare providers, it temporarily blocks pain signals to the brain, ensuring a comfortable procedure. Generally well-tolerated, potential side effects are typically mild and transient, often limited to injection site reactions like soreness, swelling, or redness. Persistent numbness or any concerning side effects necessitate immediate medical attention. Prior to administration, patients with pre-existing heart conditions or those on anti-arrhythmic medication should inform their physician. Similarly, pregnant or breastfeeding individuals require medical consultation. Drowsiness is possible; therefore, operating machinery or driving should be avoided while under the influence of this medication.
Primary Ingredients of Lignonir 2% Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Lignonir 2% Injection
Regional numbing achieved through localized anesthetic agents.
Major Benefits of Lignonir 2% Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Lignonir 2% Injection:
- Injection site reactions (pain, swelling, redness)
How to use Lignonir 2% Injection:
Administering this medication will be handled by your physician or registered nurse; self-medication is strictly prohibited.
How Lignonir 2% Injection works:
Lignonir 2% Injection provides localized pain relief by interrupting nerve impulses that would otherwise transmit pain sensations to the brain, thus reducing pain perception.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Lignonir 2% Injection alongside alcohol. Physician consultation is recommended.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Lignonir (2%) is typically deemed safe for use in pregnant individuals. Preclinical trials using animal models revealed minimal or no harmful consequences to the fetus; nonetheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Lignonir 2% Injection while breastfeeding appears to pose minimal risk. Available human data indicates negligible danger to the infant.
DrivingSAFE
Driving ability is typically unaffected by Lignonir 2% Injection.
KidneyCAUTION
Administering Lignonir 2% Injection requires careful consideration in individuals with significant renal impairment. Dosage modification of Lignonir 2% Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should use Lignonir 2% Injection judiciously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Lignonir 2% Injection :
NA
Facts to Know About Lignonir 2% Injection
| Label | Value |
|---|---|
| Chemical Category | Amide-based compound |
| Developing Habits | No. |
| Type of Therapy | Pain Relievers |
| Behavioral Class | Amide-type local anesthetics |
